| Criteria |
WHO |
EGIR |
NCEP
ATP III |
IDF |
| |
Glucose intolerance, IGT or diabetes and/or insulin resistance plus
2 or more of thefollowing: |
IR or fasting
hyperinsulinaemia
(highest 25 %) plus 2 or more of the following |
3 or more of thefollowing: |
Central obesity
(>30Kg/m2) plus 2 or more of the following |
| Glycemia |
|
Fasting glucose ≥6.1 mmol/l and <7 mmol/l |
Fasting glucose ≥ 6.1 mmol/l |
Fasting glucose ≥ 5.6 mmol/l Or previously diagnosed
Type 2 diabetes |
| Central obesity |
Waist-hip ratio
>0.90 (M)
>0.85 (F) and/or BMI>30 kg/sqm |
Waist
≥ 94 cm (M)
≥ 80 cm (F) |
Waist> 102 cm (M)> 88 cm (F) |
---- |
| Lipidemia |
TAG ≥ 1.7 mmol/lHDL-C<0.9 mmol/l (M)<1.0 mmol/l (F) |
TAG>2.0 mmol/l
HDL-C<1.0 mmol/lor dyslipidaemia
Treatment |
TAG ≥ 1.7 mmol/ HDL-C<1.0 mmol/l (M)
<1.3 mmol/l (F) |
TAG ≥ 1.7 mmol/l
or specific treatment
HDL-C<1.03 mmol/l (M)
<1.29 mmol/l (F)or specific treatment |
| Blood pressure |
>140 / 90 mm Hg |
≥ 140 and/or 90 mm Hg
or specific treatment |
≥ 135 / 85 mm Hg
or treatment |
SBP ≥ 130 mm Hg
DBP ≥ 85 mm Hg
or specific treatment |
| Others |
Micro-albuminuria |
|
|
|
